Insider Transactions in Q1 2024 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct |
4,573
-3.53%
|
$4,573
$1.53 P/Share
|
|
Mar 04
2024
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
6,095
-2.13%
|
$6,095
$1.53 P/Share
|
|
Mar 01
2024
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,770
-5.41%
|
$6,770
$1.53 P/Share
|
|
Feb 05
2024
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
1,879
-0.65%
|
$0
$0.9 P/Share
|
|
Feb 05
2024
|
Joseph Vittiglio Chief Business & Legal Officer |
SELL
Open market or private sale
|
Direct |
5,217
-10.43%
|
$0
$0.9 P/Share
|
|
Feb 05
2024
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct |
2,714
-2.05%
|
$0
$0.9 P/Share
|
|
Jan 05
2024
|
Richard A Colvin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
597
-0.47%
|
$597
$1.42 P/Share
|
|
Jan 05
2024
|
Andrew Obenshain President and CEO |
SELL
Open market or private sale
|
Direct |
3,162
-1.09%
|
$3,162
$1.43 P/Share
|